These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 32030882)
1. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts. Brough J; Jain M; Jerves T; Kruszka P; McGuffey E Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):124-128. PubMed ID: 32030882 [TBL] [Abstract][Full Text] [Related]
2. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178 [TBL] [Abstract][Full Text] [Related]
3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347 [TBL] [Abstract][Full Text] [Related]
4. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines? Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316 [TBL] [Abstract][Full Text] [Related]
6. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting. Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739 [TBL] [Abstract][Full Text] [Related]
7. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645 [TBL] [Abstract][Full Text] [Related]
9. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy. Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939 [TBL] [Abstract][Full Text] [Related]
10. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy. Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498 [TBL] [Abstract][Full Text] [Related]
11. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. Maron BJ; Maron MS; Semsarian C J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258 [TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657 [TBL] [Abstract][Full Text] [Related]
13. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Marian AJ Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830 [TBL] [Abstract][Full Text] [Related]